SGEF Activators
SGEF activators are chemicals that enhance the activity of SGEF through various signaling pathways and biochemical processes. Forskolin, a direct stimulator of adenylate cyclase, increases cAMP levels within the cell, leading to the activation of PKA. This kinase then phosphorylates a variety of proteins, including those associated with SGEF, thus enhancing SGEF's functional activity. Similarly, the cAMP analog and Dibutyryl-cAMP serve as membrane-permeable agents that activate PKA, leading to the phosphorylation of proteins that interact with SGEF, enhancing its activity within cellular signaling networks.
Phorbol 12-myrist12-myristate 13-acetate (PMA) acts as a DAG analog and is a potent activator of PKC, which can phosphorylate proteins and alter protein-protein interactions within the cell. Activation of PKC can modify the activity of SGEF either directly or indirectly by changing the dynamics of its associated signaling pathways. This can result in altered cellular responses such as changes in cytoskeletal organization, cell proliferation, and differentiation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylate cyclase, resulting in increased production of cyclic AMP (cAMP) in cells. Elevated cAMP levels can lead to the activation of protein kinase A (PKA), which can phosphorylate a range of substrates, including proteins that may interact with SGEF. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA acts as a diacylglycerol (DAG) analog, activating protein kinase C (PKC). PKC activation can lead to downstream signaling events that enhance the activity of SGEF by phosphorylation or by altering its interaction with other proteins involved in cellular signaling. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is an ionophore that increases intracellular calcium levels, which can activate calcium/calmodulin-dependent protein kinases (CaMKs). These kinases can phosphorylate proteins and potentially increase SGEF activity by enhancing its association with effector proteins. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is a potent inhibitor of protein phosphatases 1 and 2A, which leads to increased phosphorylation levels of cellular proteins. By preventing dephosphorylation, it may enhance SGEF activity through sustained phosphorylation states. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Similar to Calyculin A, Okadaic acid inhibits protein phosphatases, maintaining proteins in a phosphorylated state. This can lead to enhanced SGEF activity as a result of persistent phosphorylation of its associated signaling proteins. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a membrane-permeable cAMP analog that activates PKA. Activation of PKA can lead to phosphorylation of proteins that may enhance the activity of SGEF by altering its protein-protein interactions. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels and potentially activating CaMKs, which can indirectly enhance SGEF activity through phosphorylation events. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent kinase inhibitor, but at low concentrations, it can selectively activate certain PKC isoforms, potentially enhancing SGEF activity by mimicking diacylglycerol signaling pathways. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate interacts with its G protein-coupled receptors, potentially leading to Rho GTPase activation, which is known to interact with SGEF, thus enhancing its activity by promoting its role in cytoskeletal reorganization. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a specific PKC inhibitor, but by selectively inhibiting certain PKC isoforms, it can shift the balance of PKC activity, potentially enhancing SGEF activity by favoring the activation of SGEF-associated signaling pathways. | ||||||